首页 | 本学科首页   官方微博 | 高级检索  
检索        

C反应蛋白对晚期恶性肿瘤患者的预测价值
引用本文:陈小玲,应江山,袁苏徐,柴瑞,万伦康,张志文.C反应蛋白对晚期恶性肿瘤患者的预测价值[J].新乡医学院学报,2012,29(4):289-291.
作者姓名:陈小玲  应江山  袁苏徐  柴瑞  万伦康  张志文
作者单位:1. 上海市北站医院肿瘤科,上海200070;上海市闸北区中心医院血液肿瘤科,上海200070
2. 苏州大学附属第一医院肿瘤科,江苏苏州,215006
3. 上海市北站医院肿瘤科,上海,200070
4. 上海市北站医院检验科,上海,200070
摘    要:目的检测并探讨晚期恶性肿瘤(复发转移和终末期)患者血清中C反应蛋白(CRP)水平对病情转归的评估价值。方法收集住院治疗的60例晚期肿瘤患者(化学治疗组)、60例姑息支持治疗患者(支持组)的临床资料,记录其临床转归情况,检测患者血清标本中的CRP水平,随访预后结果。结果治疗前支持组血清CRP、白细胞(WBC)、癌胚抗原(CEA)水平高于化学治疗组(均P<0.05);支持组CRP与CEA呈正相关(r=0.26,P<0.05),化学治疗组CRP与WBC、CEA呈正相关(r1=0.26,P<0.05;r2=0.32,P<0.05);化学治疗有效者CRP较化学治疗前明显下降(t=2.64,P<0.05),而化学治疗无效者CRP较化学治疗前升高(t=-2.96,P<0.01);多因素分析提示共患疾病、CRP水平与晚期肿瘤患者预后有关(均P<0.05)。结论血清中CRP水平可作为评估晚期恶性肿瘤患者病情转归的一项参考指标。

关 键 词:恶性肿瘤  病情评估  C反应蛋白

Predictive value of serum C-reactive protein on advanced cancer patients with malignant tumor
CHEN Xiao-ling , YING Jiang-shan , YUAN Su-xu , CHAI Rui , WAN Lun-kang , ZHANG Zhi-wen.Predictive value of serum C-reactive protein on advanced cancer patients with malignant tumor[J].Journal of Xinxiang Medical College,2012,29(4):289-291.
Authors:CHEN Xiao-ling  YING Jiang-shan  YUAN Su-xu  CHAI Rui  WAN Lun-kang  ZHANG Zhi-wen
Institution:1(1.Department of Oncology,Beizhan Hospital of Shanghai,Shanghai 200070,China;2.Department of Hematology and Oncology,Zhabei District Central Hospital of Shanghai,Shanghai 200070,China;3.Department of Oncology,the First Affiliated Hospital of Soochow University,Suzhou 215006,Jiangsu Province,China;4.Laboratory Department,Beizhan Hospital of Shanghai,Shanghai 200070,China)
Abstract:Objective To evaluate the predictive value of serum C-reactive protein(CRP) on advanced cancer patients with malignant tumor(relapse and transfer and terminal stage),through detecting the serum CRP. Methods Data of 120 patients,including 60 patients with palliative chemotherapy(chemotherapy group) and 60 cases with best supportive care(supportive group) were analyzed.The level of serum CRP was quantitatively determined.Prognosis of all patients was followed up. Results Before the treatment,the levels of CRP,white blood cell(WBC) and carcinoembryonic antigen(CEA) in supportive group were higher than those in chemotherapy group(P<0.05).Before the treatment,the relationship between the serum CRP level and serum CEA level was positive(r=0.26,P<0.05) in supportive group,the serum CRP level was positive correlated with WBC level(r=0.26,P<0.05) and serum CEA level(r=0.32,P<0.05) in chemotherapy group.The change levels of CRP before or after the chemotherapy in chemotherapy group,consistency with the therapeutic effectiveness.Significant drop of CRP levels were observed in chemosensitive patients before and after chemotherapy(t=2.64,P<0.05),conversely,raised in the non-responding patients(t=-2.96,P<0.01).Multifactor logistic analysis showed that the prognosis of the advanced cancer patients with malignant tumor was related with CRP level and combined with complications. Conclusion The levels of CRP may be served as a useful index in the assessment of mortality in advanced cancer patients.
Keywords:malignant tumor  mortality evaluation  C-reactive protein
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号